# FDA recall Z-0671-2020

> **The Binding Site Group, Ltd.** · Class II · device recall initiated 2019-02-19.

## Product

Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitative in vitro determination of C-reactive protein (CRP) concentration in serum using the Binding Site Optilite analyser. Measurement of C-Reactive Protein aids in evaluation of the amount of injury to body tissues and for evaluation of infection, tissue injury, and inflammatory disorders. This test should be used in conjunction with other laboratory and clinical findings. The Optilite C-Reactive Protein Calibrator is intended for the calibration of the Optilite C-Reactive Protein Reagent on the Optilite analyser. The Optilite C-Reactive Protein Controls are intended for use in quality control by monitoring accuracy and precision for the Optilite C-Reactive Protein Reagent.

## Reason for recall

Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits

## Distribution

US Nationwide distribution in the states of CA and GA.    OUS not provided due to product being manufacture OUS

## Key facts

- **Recall number:** Z-0671-2020
- **Recalling firm:** The Binding Site Group, Ltd.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2019-02-19
- **Report date:** 2019-12-18
- **Termination date:** 2021-04-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Birmingham, N/A, United Kingdom

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0671-2020

## Citation

> AI Analytics. FDA recall Z-0671-2020. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/Z-0671-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*